How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Sell
17
IRTC Quote, Financials, Valuation and Earnings
Last price:
$154.53
Seasonality move
:
-1.57%
Day range:
$148.48 - $155.26
52-week range:
$92.52 - $212.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.74x
P/B ratio:
39.38x
Volume:
751.1K
Avg. volume:
603.3K
1-year change:
35.03%
Market cap:
$4.8B
Revenue:
$591.8M
EPS (TTM):
-$1.62
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IRTC
iRhythm Holdings, Inc.
|
$201.8M | $0.06 | 21.21% | -49.15% | $220.60 |
|
ATEC
Alphatec Holdings, Inc.
|
$212.7M | $0.04 | 18.01% | -91.85% | $24.38 |
|
ATRC
AtriCure, Inc.
|
$140.5M | -$0.05 | 12.71% | -83.91% | $52.78 |
|
BAX
Baxter International, Inc.
|
$2.8B | $0.54 | 0.5% | 98.19% | $23.13 |
|
IART
Integra LifeSciences Holdings Corp.
|
$429.6M | $0.80 | -2.94% | 217.65% | $15.50 |
|
TNDM
Tandem Diabetes Care, Inc.
|
$277.2M | -$0.09 | 6.15% | -78.57% | $25.95 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IRTC
iRhythm Holdings, Inc.
|
$148.99 | $220.60 | $4.8B | -- | $0.00 | 0% | 6.74x |
|
ATEC
Alphatec Holdings, Inc.
|
$14.83 | $24.38 | $2.2B | -- | $0.00 | 0% | 3.02x |
|
ATRC
AtriCure, Inc.
|
$36.93 | $52.78 | $1.8B | -- | $0.00 | 0% | 3.39x |
|
BAX
Baxter International, Inc.
|
$20.07 | $23.13 | $10.3B | 167.20x | $0.01 | 2.59% | 0.93x |
|
IART
Integra LifeSciences Holdings Corp.
|
$11.09 | $15.50 | $863.8M | 70.14x | $0.00 | 0% | 0.52x |
|
TNDM
Tandem Diabetes Care, Inc.
|
$19.76 | $25.95 | $1.3B | -- | $0.00 | 0% | 1.31x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IRTC
iRhythm Holdings, Inc.
|
85.74% | 2.412 | 13.23% | 4.47x |
|
ATEC
Alphatec Holdings, Inc.
|
94.39% | 1.682 | 27.26% | 1.21x |
|
ATRC
AtriCure, Inc.
|
14.82% | 1.966 | 4.73% | 2.72x |
|
BAX
Baxter International, Inc.
|
57.29% | -0.374 | 83.18% | 0.96x |
|
IART
Integra LifeSciences Holdings Corp.
|
65.91% | 0.037 | 179.84% | 1.47x |
|
TNDM
Tandem Diabetes Care, Inc.
|
77.16% | 1.942 | 54.61% | 1.79x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IRTC
iRhythm Holdings, Inc.
|
$137.1M | -$4M | -6.2% | -54.18% | -2.08% | $20.1M |
|
ATEC
Alphatec Holdings, Inc.
|
$118.1M | -$9.4M | -25.96% | -1495.13% | -4.79% | $3.1M |
|
ATRC
AtriCure, Inc.
|
$100.6M | $208K | -5.3% | -6.2% | 0.16% | $24.1M |
|
BAX
Baxter International, Inc.
|
$938M | $194M | -1.9% | -4.83% | 6.84% | $126M |
|
IART
Integra LifeSciences Holdings Corp.
|
$226.1M | $25.9M | -14.85% | -37.15% | 6.43% | $25.8M |
|
TNDM
Tandem Diabetes Care, Inc.
|
$134.3M | -$20.1M | -31.16% | -110.24% | -8.05% | $4.2M |
iRhythm Holdings, Inc. vs. Competitors
-
Which has Higher Returns IRTC or ATEC?
Alphatec Holdings, Inc. has a net margin of -2.7% compared to iRhythm Holdings, Inc.'s net margin of -14.54%. iRhythm Holdings, Inc.'s return on equity of -54.18% beat Alphatec Holdings, Inc.'s return on equity of -1495.13%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Holdings, Inc.71.09% -$0.16 $854.9M ATECAlphatec Holdings, Inc.60.12% -$0.19 $626.3M -
What do Analysts Say About IRTC or ATEC?
iRhythm Holdings, Inc. has a consensus price target of $220.60, signalling upside risk potential of 48.06%. On the other hand Alphatec Holdings, Inc. has an analysts' consensus of $24.38 which suggests that it could grow by 64.43%. Given that Alphatec Holdings, Inc. has higher upside potential than iRhythm Holdings, Inc., analysts believe Alphatec Holdings, Inc. is more attractive than iRhythm Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Holdings, Inc.12 1 0 ATECAlphatec Holdings, Inc.8 1 0 -
Is IRTC or ATEC More Risky?
iRhythm Holdings, Inc. has a beta of 1.121, which suggesting that the stock is 12.075% more volatile than S&P 500. In comparison Alphatec Holdings, Inc. has a beta of 1.013, suggesting its more volatile than the S&P 500 by 1.311%.
-
Which is a Better Dividend Stock IRTC or ATEC?
iRhythm Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alphatec Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iRhythm Holdings, Inc. pays -- of its earnings as a dividend. Alphatec Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or ATEC?
iRhythm Holdings, Inc. quarterly revenues are $192.9M, which are smaller than Alphatec Holdings, Inc. quarterly revenues of $196.5M. iRhythm Holdings, Inc.'s net income of -$5.2M is higher than Alphatec Holdings, Inc.'s net income of -$28.6M. Notably, iRhythm Holdings, Inc.'s price-to-earnings ratio is -- while Alphatec Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Holdings, Inc. is 6.74x versus 3.02x for Alphatec Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Holdings, Inc.6.74x -- $192.9M -$5.2M ATECAlphatec Holdings, Inc.3.02x -- $196.5M -$28.6M
-
Which has Higher Returns IRTC or ATRC?
AtriCure, Inc. has a net margin of -2.7% compared to iRhythm Holdings, Inc.'s net margin of -0.2%. iRhythm Holdings, Inc.'s return on equity of -54.18% beat AtriCure, Inc.'s return on equity of -6.2%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Holdings, Inc.71.09% -$0.16 $854.9M ATRCAtriCure, Inc.74.9% -$0.01 $559.4M -
What do Analysts Say About IRTC or ATRC?
iRhythm Holdings, Inc. has a consensus price target of $220.60, signalling upside risk potential of 48.06%. On the other hand AtriCure, Inc. has an analysts' consensus of $52.78 which suggests that it could grow by 42.91%. Given that iRhythm Holdings, Inc. has higher upside potential than AtriCure, Inc., analysts believe iRhythm Holdings, Inc. is more attractive than AtriCure, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Holdings, Inc.12 1 0 ATRCAtriCure, Inc.5 0 0 -
Is IRTC or ATRC More Risky?
iRhythm Holdings, Inc. has a beta of 1.121, which suggesting that the stock is 12.075% more volatile than S&P 500. In comparison AtriCure, Inc. has a beta of 1.401, suggesting its more volatile than the S&P 500 by 40.078%.
-
Which is a Better Dividend Stock IRTC or ATRC?
iRhythm Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AtriCure, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iRhythm Holdings, Inc. pays -- of its earnings as a dividend. AtriCure, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or ATRC?
iRhythm Holdings, Inc. quarterly revenues are $192.9M, which are larger than AtriCure, Inc. quarterly revenues of $134.3M. iRhythm Holdings, Inc.'s net income of -$5.2M is lower than AtriCure, Inc.'s net income of -$267K. Notably, iRhythm Holdings, Inc.'s price-to-earnings ratio is -- while AtriCure, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Holdings, Inc. is 6.74x versus 3.39x for AtriCure, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Holdings, Inc.6.74x -- $192.9M -$5.2M ATRCAtriCure, Inc.3.39x -- $134.3M -$267K
-
Which has Higher Returns IRTC or BAX?
Baxter International, Inc. has a net margin of -2.7% compared to iRhythm Holdings, Inc.'s net margin of -1.8%. iRhythm Holdings, Inc.'s return on equity of -54.18% beat Baxter International, Inc.'s return on equity of -4.83%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Holdings, Inc.71.09% -$0.16 $854.9M BAXBaxter International, Inc.33.09% $0.02 $16.9B -
What do Analysts Say About IRTC or BAX?
iRhythm Holdings, Inc. has a consensus price target of $220.60, signalling upside risk potential of 48.06%. On the other hand Baxter International, Inc. has an analysts' consensus of $23.13 which suggests that it could grow by 15.26%. Given that iRhythm Holdings, Inc. has higher upside potential than Baxter International, Inc., analysts believe iRhythm Holdings, Inc. is more attractive than Baxter International, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Holdings, Inc.12 1 0 BAXBaxter International, Inc.2 13 1 -
Is IRTC or BAX More Risky?
iRhythm Holdings, Inc. has a beta of 1.121, which suggesting that the stock is 12.075% more volatile than S&P 500. In comparison Baxter International, Inc. has a beta of 0.594, suggesting its less volatile than the S&P 500 by 40.626%.
-
Which is a Better Dividend Stock IRTC or BAX?
iRhythm Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Baxter International, Inc. offers a yield of 2.59% to investors and pays a quarterly dividend of $0.01 per share. iRhythm Holdings, Inc. pays -- of its earnings as a dividend. Baxter International, Inc. pays out 180.98% of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or BAX?
iRhythm Holdings, Inc. quarterly revenues are $192.9M, which are smaller than Baxter International, Inc. quarterly revenues of $2.8B. iRhythm Holdings, Inc.'s net income of -$5.2M is higher than Baxter International, Inc.'s net income of -$51M. Notably, iRhythm Holdings, Inc.'s price-to-earnings ratio is -- while Baxter International, Inc.'s PE ratio is 167.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Holdings, Inc. is 6.74x versus 0.93x for Baxter International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Holdings, Inc.6.74x -- $192.9M -$5.2M BAXBaxter International, Inc.0.93x 167.20x $2.8B -$51M
-
Which has Higher Returns IRTC or IART?
Integra LifeSciences Holdings Corp. has a net margin of -2.7% compared to iRhythm Holdings, Inc.'s net margin of -1.34%. iRhythm Holdings, Inc.'s return on equity of -54.18% beat Integra LifeSciences Holdings Corp.'s return on equity of -37.15%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Holdings, Inc.71.09% -$0.16 $854.9M IARTIntegra LifeSciences Holdings Corp.56.24% -$0.07 $3B -
What do Analysts Say About IRTC or IART?
iRhythm Holdings, Inc. has a consensus price target of $220.60, signalling upside risk potential of 48.06%. On the other hand Integra LifeSciences Holdings Corp. has an analysts' consensus of $15.50 which suggests that it could grow by 39.77%. Given that iRhythm Holdings, Inc. has higher upside potential than Integra LifeSciences Holdings Corp., analysts believe iRhythm Holdings, Inc. is more attractive than Integra LifeSciences Holdings Corp..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Holdings, Inc.12 1 0 IARTIntegra LifeSciences Holdings Corp.2 4 2 -
Is IRTC or IART More Risky?
iRhythm Holdings, Inc. has a beta of 1.121, which suggesting that the stock is 12.075% more volatile than S&P 500. In comparison Integra LifeSciences Holdings Corp. has a beta of 1.025, suggesting its more volatile than the S&P 500 by 2.536%.
-
Which is a Better Dividend Stock IRTC or IART?
iRhythm Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integra LifeSciences Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iRhythm Holdings, Inc. pays -- of its earnings as a dividend. Integra LifeSciences Holdings Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or IART?
iRhythm Holdings, Inc. quarterly revenues are $192.9M, which are smaller than Integra LifeSciences Holdings Corp. quarterly revenues of $402.1M. iRhythm Holdings, Inc.'s net income of -$5.2M is higher than Integra LifeSciences Holdings Corp.'s net income of -$5.4M. Notably, iRhythm Holdings, Inc.'s price-to-earnings ratio is -- while Integra LifeSciences Holdings Corp.'s PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Holdings, Inc. is 6.74x versus 0.52x for Integra LifeSciences Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Holdings, Inc.6.74x -- $192.9M -$5.2M IARTIntegra LifeSciences Holdings Corp.0.52x 70.14x $402.1M -$5.4M
-
Which has Higher Returns IRTC or TNDM?
Tandem Diabetes Care, Inc. has a net margin of -2.7% compared to iRhythm Holdings, Inc.'s net margin of -8.49%. iRhythm Holdings, Inc.'s return on equity of -54.18% beat Tandem Diabetes Care, Inc.'s return on equity of -110.24%.
Company Gross Margin Earnings Per Share Invested Capital IRTCiRhythm Holdings, Inc.71.09% -$0.16 $854.9M TNDMTandem Diabetes Care, Inc.53.88% -$0.31 $582.2M -
What do Analysts Say About IRTC or TNDM?
iRhythm Holdings, Inc. has a consensus price target of $220.60, signalling upside risk potential of 48.06%. On the other hand Tandem Diabetes Care, Inc. has an analysts' consensus of $25.95 which suggests that it could grow by 31.34%. Given that iRhythm Holdings, Inc. has higher upside potential than Tandem Diabetes Care, Inc., analysts believe iRhythm Holdings, Inc. is more attractive than Tandem Diabetes Care, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IRTCiRhythm Holdings, Inc.12 1 0 TNDMTandem Diabetes Care, Inc.7 13 0 -
Is IRTC or TNDM More Risky?
iRhythm Holdings, Inc. has a beta of 1.121, which suggesting that the stock is 12.075% more volatile than S&P 500. In comparison Tandem Diabetes Care, Inc. has a beta of 1.682, suggesting its more volatile than the S&P 500 by 68.218%.
-
Which is a Better Dividend Stock IRTC or TNDM?
iRhythm Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tandem Diabetes Care, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. iRhythm Holdings, Inc. pays -- of its earnings as a dividend. Tandem Diabetes Care, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IRTC or TNDM?
iRhythm Holdings, Inc. quarterly revenues are $192.9M, which are smaller than Tandem Diabetes Care, Inc. quarterly revenues of $249.3M. iRhythm Holdings, Inc.'s net income of -$5.2M is higher than Tandem Diabetes Care, Inc.'s net income of -$21.2M. Notably, iRhythm Holdings, Inc.'s price-to-earnings ratio is -- while Tandem Diabetes Care, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iRhythm Holdings, Inc. is 6.74x versus 1.31x for Tandem Diabetes Care, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IRTCiRhythm Holdings, Inc.6.74x -- $192.9M -$5.2M TNDMTandem Diabetes Care, Inc.1.31x -- $249.3M -$21.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.7T
P/E Ratio: 66x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Buy
78
GDXU alert for Jan 31
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 38.85% over the past day.
Buy
67
PFSI alert for Jan 30
PennyMac Financial Services, Inc. [PFSI] is down 33.21% over the past day.
Buy
88
JNUG alert for Jan 30
Direxion Daily Junior Gold Miners Idx Bull 2X Shs [JNUG] is down 26.98% over the past day.
